SS 31 - Breast Cancer 3: Toxicity

Moderator(s)

• MC

  Manjeet Chadha, MD, FASTRO

  Mount Sinai School of Medicine
  New York, NY, United States
• 

  Susan McDuff, MD, PhD

  Duke University Medical Center
  Durham, NC

Presentations:

• 12:45 PM – 12:55 PM ET

  The Association of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events Following Modern Breast Radiotherapy
  

  Presenter: Michael Roumeliotis, PhD – Johns Hopkins University
• 12:55 PM – 1:05 PM ET

  A Virtual Program for Fatigue among Women Undergoing Radiation Treatment: Results from a Randomized Controlled Basket Trial
  

  Presenter: Erin Gillespie, MD, MPH – University of Washington-Fred Hutchinson Cancer Center
• 1:05 PM – 1:15 PM ET

  Safety and Efficacy of Combined Trastuzumab-Deruxtecan and Concurrent Radiation Therapy in Breast Cancer: The TENDANCE Multicentric French Study (Trastuzumab-Deruxtecan and Concurrent Radiation Therap
  

  Presenter: Kamel Debbi, MD – Henri Mondor University Hospital and Faculte de Medecin de Creteil Paris XII
• 1:15 PM – 1:25 PM ET

  Characterization of Skin Microbiome Profile before and during Radiation Therapy and Its Correlation to the Occurrence and Severity of Radiation Dermatitis
  

  Presenter: Roxolyana Abdah-Bortnyak, MD – Rambam Health Care Campus
• 1:25 PM – 1:35 PM ET

  A Phase I/II Trial of Spectrophotometric Skin Changes during and after Radiotherapy and Correlation with Radiation-Induced Skin Toxicity in Breast Cancer Patients with Skin of Color
  

  Presenter: Juhi Purswani, MD – New York University School of Medicine
• 1:35 PM – 1:45 PM ET

  Analysis of Rib Fracture Risk after Breast Radiation with Various Dose Fractionations
  

  Presenter: Jackson Howell, MD – University of Utah Huntsman Cancer Institute
• 1:45 PM – 1:55 PM ET

  Discussant
  

  Discussant: Youlia Kirova, MD – Institut Curie